Results 11 to 20 of about 447,481 (255)
The evidence for a role of bacteria and viruses in cardiovascular disease [PDF]
Scripta Medica, 2022 Inflammation plays a critical role in atherosclerosis and cardiovascular disease. Bacteria and viruses are major causative agents of inflammation in the body which normally develops as a response to infection.
Pierce Grant N. +5 more
doaj +1 more source
Persistence and Adherence to Cardiovascular Medicines in Australia
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023 Background The burden of cardiovascular disease is increasing, with many people treated for multiple cardiovascular conditions. We examined persistence and adherence to medicines for cardiovascular disease treatment or prevention in Australia.
Juliana de Oliveira Costa +5 more
doaj +1 more source
Frontiers in Pediatrics, 2021 We aimed to determine the association of vasoactive-inotropic score (VIS) and vasoactive-ventilation-renal (VVR) score with in-hospital mortality and functional outcomes at discharge of children who receive ECMO.
Ira Shukla +3 more
doaj +1 more source
Frontiers in Pharmacology, 2021 Nowadays, nitrogenous heterocyclic molecules have attracted a great deal of interest among medicinal chemists. Among these potential heterocyclic drugs, benzimidazole scaffolds are considerably prevalent.
Shejuti Rahman Brishty +5 more
doaj +1 more source
Challenges in the treatment of hypotension in an extremely preterm neonate [PDF]
Srpski Arhiv za Celokupno LekarstvoIntroduction. Hypotension is often seen in preterm neonates, as a result of various factors such as immature myocardium, transitional circulation, perinatal hypoxia, positive-pressure ventilation, and relative adrenal insufficiency. The leading causes of
Palić Ilija +3 more
doaj +1 more source
The impact of cardiovascular drugs on the efficacy of local anesthesia in dentistry
Biomedical Papers, 2016 Background and Aim. Drugs used chronically by patients with diseases of the cardiovascular system (group C of the ATC classification) may act on adrenergic receptors and/or certain ion channels, which gives them the potential to interact with the action
Мarko J. Milosavljevic +1 more
doaj +1 more source
Natural AMPK Activators in Cardiovascular Disease Prevention
Frontiers in Pharmacology, 2022 Cardiovascular diseases (CVD), as a life-threatening global disease, is receiving worldwide attention. Seeking novel therapeutic strategies and agents is of utmost importance to curb CVD.
Reza Heidary Moghaddam +8 more
doaj +1 more source
Diabetes: how to manage cardiovascular risk in secondary prevention patients
Drugs in Context, 2022 Atherosclerotic cardiovascular disease (ASCVD) commonly affects people with type 2 diabetes (T2D). Historically, traditional cardiovascular (CV) risk-lowering therapies in patients with T2D and ASCVD have included antiplatelet agents, blood pressure ...
Sarah L Anderson, Joel C Marrs
doaj +1 more source
American Journal of Preventive Cardiology, 2023 Cardiovascular disease remains one of the most prominent global health problems and has been demonstrated to disproportionally affect certain communities.
Apurva Khedagi +9 more
doaj +1 more source
Acta Scientiarum: Technology, 2022 Failure of hemostasis and the formation of blood clots in the arteries are the main reasons that provoke the onset of cardiovascular diseases (CVDs) such as myocardial infarction and ischemic stroke.
Ali Nawaz +6 more
doaj +1 more source